Showing results (81-90 of 236) with videos related to
Sort By:
Pageof 24
Journal of Hepatology|January 4, 2014
Management of infections pre- and post-liver transplantation: report of an AISF consensus conferenceStefano Fagiuoli, Agostino Colli, Raffaele Bruno, et al.Journal of Hepatology|March 22, 2017
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipientsLuca S Belli, Christophe Duvoux, Marina Berenguer, et al.HIV Clinical Trials|August 21, 2002
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCVMassimo Puoti, Barbara Zanini, Raffaele Bruno, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 12, 2013
Management of infections in cirrhotic patients: report of a consensus conferenceStefano Fagiuoli, Agostino Colli, Raffaele Bruno, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2017
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIVAndrea De Luca, Patrizia Lorenzini, Antonella Castagna, et al.HIV Medicine|June 5, 2024
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapyVincenzo Malagnino, Alessandro Cozzi-Lepri, Valentina Svicher, et al.The Journal of Antimicrobial Chemotherapy|February 13, 2023
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA studyAntonella D'arminio Monforte, Alessandro Tavelli, Matteo Sala, et al.International Journal of STD & AIDS|November 23, 2025
Two-drugs regimens did not influence total HIV-1 DNA in people living with HIVGabriele Cavazza, Alice Nava, Elena Nicolini, et al.The Journal of Antimicrobial Chemotherapy|January 20, 2009
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosisFrancesca Gatti, Paola Nasta, Arianna Loregian, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2020
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohortsRoberto Rossotti, Alessandro Tavelli, Stefano Bonora, et al.Pageof 24